Carolyn Charles
Interventional Pain Medicine · Pearland, TXNPI 1124678511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $605, 5.1 times the $118 reported in 2021. That places this record below the midpoint for interventional pain medicine clinicians in TX, where the typical reported total is $6,464.
Across 61 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$190
- AbbVie$160
- Saluda Medical Americas, Inc.$117
- Vertex$100
- Merck$79
- Valinor Pharma, LLC$63
- plus $582 from 20 others
What the payments were for
- Food & beverage$1,290100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $190 |
| AbbVie | 6 | $160 |
| Saluda Medical Americas, Inc. | 5 | $117 |
| Vertex | 3 | $100 |
| Merck | 4 | $79 |
| Valinor Pharma, LLC | 3 | $63 |
| Azurity Pharmaceuticals, Inc. | 3 | $61 |
| Averitas Pharma Inc. | 3 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Boehringer Ingelheim | 2 | $41 |
| Pfizer | 2 | $40 |
| Boston Scientific | 1 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Painteq LLC | 1 | $31 |
| Bioventus LLC | 1 | $31 |
| Nalu Medical, Inc. | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $27 |
| Indivior Inc. | 1 | $27 |
| Curonix LLC | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| USWM, LLC | 1 | $14 |
| Amgen | 1 | $13 |
How this compares
$1,290 in reported general payments places this provider in the 20th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Pearland
- Jay LafleurPearland$25K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.